Expertise
Our experience makes the difference
Prioritis, an IQVIA business provides strategic expertise and technical support to global market access and pricing departments. Present at each stage of the reimbursement process, Prioritis’ expertise in value based pricing and market access enables the company to deliver key advice as well as carry out detailed work as an “integrated” partner. We set up a project team for each case and ensure a thorough understanding of every situation regardless of the product and the disease area.
Our missions are diverse in nature and may lead us to structure and write assessment and pricing dossiers, assist our customers with appeals, consult on specific questions with our KOL and payers network.
Ongoing commitment
Prioritis is committed to providing a dedicated and individual follow up.
- One contact only to construct and design the value dossier
- Immediate availability and complete responsiveness: RFP, quotations and draft agreements are processed in 24 hours
- Team of key experts: widely recognized KOL and payers provide essential insight in each therapeutic area
- Proven expertise: our know-how is recognized by our customer constant satisfaction and the steady increase of the dossiers entrusted to us
- Guaranteed confidentiality: respect of confidentiality at all stages of our contribution.
Generating key performance indicators from clinical and economic data, time to reimbursement and price negotiations
Analytics thinking: A full range of expertise
Thanks to the exceptional ability of its team, Prioritis fully assists its clients with a critical analysis and strategic insight into specific products or therapeutic area to support business growth:
- Product landscaping and positioning
- Product risk analysis
- Product potential based on clinical data analysis
- Payer evidence requirements, including scientific advice
Experience
Our experience and comprehension can make the difference
Prioritis is able to identify, understand and solve any situation met by an innovative drug or medical device on its way to becoming a market leader.
Our approach to product valuation and strategy development is unique and adapted to the complexity of each case.
Our level of expertise and the privileged relationship and comprehension that we have with the regulators and authorities are our strength and our assets.
